Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vericel (VCEL) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to $17.9 million.

  • Vericel's Cost of Revenue rose 1025.1% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.7 million, marking a year-over-year increase of 466.25%. This contributed to the annual value of $65.1 million for FY2024, which is 512.92% up from last year.
  • As of Q3 2025, Vericel's Cost of Revenue stood at $17.9 million, which was up 1025.1% from $16.6 million recorded in Q2 2025.
  • In the past 5 years, Vericel's Cost of Revenue ranged from a high of $17.9 million in Q3 2025 and a low of $11.6 million during Q1 2021
  • For the 5-year period, Vericel's Cost of Revenue averaged around $14.9 million, with its median value being $15.0 million (2023).
  • Per our database at Business Quant, Vericel's Cost of Revenue soared by 4560.05% in 2021 and then surged by 50.06% in 2024.
  • Quarter analysis of 5 years shows Vericel's Cost of Revenue stood at $13.6 million in 2021, then grew by 6.53% to $14.4 million in 2022, then grew by 14.15% to $16.5 million in 2023, then rose by 2.35% to $16.9 million in 2024, then grew by 6.17% to $17.9 million in 2025.
  • Its Cost of Revenue was $17.9 million in Q3 2025, compared to $16.6 million in Q2 2025 and $16.3 million in Q1 2025.